Metagenomi, Inc.
MGX
$1.86
-$0.05-2.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -57.45% | -63.02% | -22.46% | -6.87% | 76.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.45% | -63.02% | -22.46% | -6.87% | 76.48% |
| Cost of Revenue | -20.53% | -20.03% | -6.43% | -2.16% | 24.86% |
| Gross Profit | -68.36% | -3.62% | -9.66% | -1.85% | 26.73% |
| SG&A Expenses | -18.22% | -22.25% | -9.78% | -3.53% | 29.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.99% | -20.51% | -7.23% | -2.48% | 25.84% |
| Operating Income | -24.46% | 4.17% | -2.11% | 0.05% | 6.12% |
| Income Before Tax | -53.53% | 0.82% | -48.52% | -12.17% | -16.45% |
| Income Tax Expenses | 102.00% | -- | -144.31% | -274.63% | -215.86% |
| Earnings from Continuing Operations | -85.38% | 0.43% | -21.27% | 5.28% | 17.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -85.38% | 0.43% | -21.27% | 5.28% | 17.44% |
| EBIT | -24.46% | 4.17% | -2.11% | 0.05% | 6.12% |
| EBITDA | -26.35% | 4.67% | -0.88% | 1.05% | 8.25% |
| EPS Basic | -82.74% | 43.15% | 88.93% | 91.23% | 80.86% |
| Normalized Basic EPS | -41.49% | 43.37% | 90.37% | 90.64% | 78.54% |
| EPS Diluted | -82.74% | 43.15% | 88.93% | 91.23% | 80.86% |
| Normalized Diluted EPS | -41.49% | 43.37% | 90.37% | 90.64% | 78.54% |
| Average Basic Shares Outstanding | 1.45% | 75.13% | 995.76% | 979.90% | 331.37% |
| Average Diluted Shares Outstanding | 1.45% | 75.13% | 995.76% | 979.90% | 331.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |